발행물
컨퍼런스
2012 KSBMB Annual Meeting
,
Genetically engineered stem cells expressing cytosine deaminase and interferon-beta have a therapeutic effect against human hepatocarcinoma cells by their tumor tropic ability
A migratory effect of therapeutic stem cells with cytosine deaminase and human interferon-beta induced the cell growth inhibition of human colorectal cancer cells
Treatment of breast cancer cells with amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase resulted in their growth inhibition in cellular and xenograft mouse models
Treatment with therapeutic stem cells expressing a suicide gene and interferon-beta resulted in the growth inhibition of breast tumor and migrated to breast cancer cells via their chemoattractant factors
Therapeutic efficacy of genetically engineered stem cells expressing yeast cytosine deaminase gene in lung cancer metastasis to brain in the presence of a prodrug